Zhang Luyue, Su Liqian, Wu Lina, Zhou Weikai, Xie Jing, Fan Yi, Zhou Xuedong, Zhou Changchun, Cui Yujia, Sun Jianxun
State Key Laboratory of Oral Disease & National Center for Stomatology & National Clinical Center for Oral Diseases & Department of Operative Dentistry and Endodontics, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu 610041, China.
J Mater Chem B. 2025 Feb 19;13(8):2611-2639. doi: 10.1039/d4tb02314e.
Bone defects are a prevalent issue resulting from various factors, such as trauma, degenerative diseases, congenital disabilities, and the surgical removal of tumors. Current methods for bone regeneration have limitations. In this context, the fusion of tissue engineering and microfluidics has emerged as a promising strategy in the field of bone regeneration. This study describes the classification of microfluidic devices based on the nature of flow and channel type, as well as the materials and techniques required. An overview of microfluidic methods used to prepare hydrogels and the advantages of using these hydrogels in bone tissue engineering (BTE) combining several basic elements of BTE to highlight its advantages is provided. Furthermore, this work emphasizes the benefits of using hydrogels prepared microfluidics over conventional hydrogels in BTE because of their controlled release of cargo, they can be used for injection, simplify the steps of single-cell encapsulation and have the advantages of high-throughput and precise preparation. Additionally, organ-on-a-chip models fabricated microfluidics offer a platform for studying cell and tissue behaviors in an authentic and dynamic environment. Moreover, microfluidic devices can be utilized for noninvasive diagnosis and therapy. Finally, this paper summarizes the preclinical and clinical applications of hydrogels prepared microfluidics for bone regeneration by focusing on their current developmental status, limitations associated with their application, and future challenges, which underscore their potential impacts on advancing regenerative medicine practices.
骨缺损是由多种因素引起的普遍问题,如创伤、退行性疾病、先天性残疾以及肿瘤的手术切除。目前的骨再生方法存在局限性。在此背景下,组织工程与微流控技术的融合已成为骨再生领域一种有前景的策略。本研究描述了基于流动性质和通道类型的微流控装置分类,以及所需的材料和技术。提供了用于制备水凝胶的微流控方法概述,以及在骨组织工程(BTE)中使用这些水凝胶结合BTE的几个基本要素以突出其优势。此外,这项工作强调了在BTE中使用通过微流控制备的水凝胶优于传统水凝胶的优点,因为它们能控制货物释放、可用于注射、简化单细胞封装步骤且具有高通量和精确制备的优势。此外,通过微流控制造的芯片器官模型为在真实动态环境中研究细胞和组织行为提供了一个平台。而且,微流控装置可用于无创诊断和治疗。最后,本文通过关注其当前发展状况、应用相关的局限性和未来挑战,总结了通过微流控制备的水凝胶在骨再生方面的临床前和临床应用,这些突出了它们对推进再生医学实践的潜在影响。
J Mater Chem B. 2025-2-19
Tissue Eng Part B Rev. 2024-10
ACS Biomater Sci Eng. 2024-9-9
Biomed Mater Eng. 2006
J Funct Biomater. 2025-5-8